Skip to main content
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
11.41
+0.22 (1.97%)
Oct 4, 2024, 4:00 PM EDT - Market closed

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $17.97M in the quarter ending June 30, 2024, a decrease of -4.88%. This brings the company's revenue in the last twelve months to $71.96M, down -10.71% year-over-year. In the fiscal year ending September 30, 2023, Enanta Pharmaceuticals had annual revenue of $79.20M, down -8.07%.

Revenue (ttm)
$71.96M
Revenue Growth
-10.71%
P/S Ratio
3.35
Revenue / Employee
$496,276
Employees
145
Market Cap
241.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.77B
Adaptimmune Therapeutics 141.46M
Fulcrum Therapeutics 81.63M
Codexis 60.89M
Utah Medical Products 46.58M
Zentalis Pharmaceuticals 40.56M
Sera Prognostics 107.00K
Revenue Rankings

ENTA News

More News